Peijie He | Medicine and Dentistry | Innovation Excellence Award

Prof. Dr. Peijie He | Medicine and Dentistry | Innovation Excellence Award

ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China

Professor Peijie He, MD, PhD, is a senior surgeon, clinician-scientist, and academic leader in laryngology and head & neck surgery at the Eye and ENT Hospital of Fudan University, Shanghai. As Chief Physician of the Division of Laryngology, his career integrates advanced clinical practice, translational research, and postgraduate medical education, with a sustained focus on function-preserving treatment strategies for laryngeal and hypopharyngeal diseases. His academic training spans China and South Korea, combining clinical otolaryngology with laser medicine and photodynamic therapy, which has shaped his distinctive interdisciplinary research profile. Professor He has made substantial contributions to minimally invasive laryngeal surgery, phonosurgery, and laser-based therapies, particularly the clinical application of CO₂ and KTP lasers, photodynamic therapy, and office-based interventions for vocal fold leukoplakia, papillomatosis, hemangioma, and early-stage laryngeal carcinoma. His work bridges clinical innovation with mechanistic research, elucidating oxidative stress, ROS-mediated pathways, and apoptosis mechanisms in laryngeal cancer cells, thereby strengthening the scientific foundation of modern laryngological treatments. He has authored and co-authored over 30 peer-reviewed international publications in leading journals such as The Laryngoscope, Journal of Voice, European Archives of Oto-Rhino-Laryngology, Lasers in Medical Science, and Oncology Letters, with multiple papers as corresponding author. His research is frequently cited and widely recognized within the otolaryngology community. Professor He has served as Principal Investigator on multiple competitive grants, including projects funded by the National Natural Science Foundation of China and the Shanghai Municipal Health Commission, supporting both basic and clinically translational research.

Citation Metrics (Scopus)
600
500
300

100

Citations
602
Documents
52
h-index
14

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Dr. Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Mary Bird Perkins Cancer Center | United States

Dr. Sotirios Stathakis is an accomplished medical physicist with extensive experience in radiation oncology, advanced treatment planning, and patient safety in cancer care. Currently serving as the Chief of Physics at Mary Bird Perkins Cancer Center and Adjunct Professor at Louisiana State University, he has established himself as a leader in both clinical and academic domains. His work bridges fundamental research and real-world clinical application, focusing on improving the accuracy, efficiency, and safety of radiotherapy treatments. With a career spanning over two decades, Dr. Stathakis has played a pivotal role in advancing technologies such as intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), Monte Carlo simulations, and adaptive radiotherapy. He has supervised graduate students, medical residents, and postdoctoral fellows, contributing to the development of the next generation of medical physicists. Dr. Stathakis is internationally recognized for his innovative contributions to medical physics, publishing widely in peer-reviewed journals and presenting at global conferences. His leadership in quality assurance (QA) protocols, radiotherapy safety standards, and patient-centered innovations has earned him professional recognition as a Fellow of the American Association of Physicists in Medicine (AAPM). He continues to expand his research by integrating artificial intelligence, patient education, and wearable technology into cancer care.

Professional Profile

Scopus | ORCID

Education

Dr. Sotirios Stathakis has a strong academic background rooted in physics and medical physics, which forms the foundation of his distinguished career in cancer treatment and research. He began his academic journey with a Bachelor of Science in Physics from the University of Waterloo, Canada, where he developed a strong foundation in core physical sciences and problem-solving skills. Driven by an interest in applying physics to medicine, he pursued a Master of Science in Medical Physics at the University of Aberdeen, United Kingdom. Here, he received specialized training in radiological sciences, medical imaging, and radiotherapy applications, which fueled his passion for research in patient care. His academic progression culminated in a Ph.D. in Medical Physics from the University of Patras, Greece, where his doctoral work focused on advanced radiation dosimetry and optimization of treatment planning systems. His doctoral training allowed him to explore Monte Carlo simulations and radiation safety protocols, which later became key aspects of his professional contributions. This comprehensive education, spanning North America and Europe, equipped him with a unique global perspective and multidisciplinary expertise. It also prepared him to integrate clinical practice with research, ultimately shaping his career as a recognized leader in medical physics and radiation oncology.

Professional Experience

Dr. Sotirios Stathakis has accumulated diverse professional experience that reflects his dual commitment to academic research and clinical application. He began his career in Europe, contributing to medical physics research before moving to the United States, where he established himself in leading academic and clinical institutions. At the University of Texas Health Science Center San Antonio (UTHSA), he served as a Professor and Medical Physicist, taking on responsibilities that included treatment planning, clinical implementation of new radiotherapy techniques, and the supervision of graduate students and medical residents. His academic contributions included teaching advanced courses in radiation oncology physics and mentoring Ph.D. dissertations. He later transitioned to his current role as Chief of Physics at Mary Bird Perkins Cancer Center, where he oversees medical physics operations across multiple oncology centers. In this role, he leads a team of physicists and ensures the safe and effective delivery of radiation treatments to cancer patients. His position as Adjunct Professor at Louisiana State University complements his clinical work, as he continues to teach and mentor the next generation of medical physicists. Throughout his career, Dr. Stathakis has balanced leadership, clinical service, and research, contributing to advancements in both patient care and academic knowledge.

Research Interests

Dr. Sotirios Stathakis’s research interests lie at the intersection of clinical innovation, radiation therapy optimization, and patient-centered approaches. A central focus of his research is the improvement of treatment planning systems, particularly through advanced modeling such as Monte Carlo simulations, which enhance accuracy in dose calculations. He has contributed to the development and refinement of quality assurance (QA) protocols, ensuring precision in intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). Another important area of his research includes studying the secondary cancer risks associated with radiotherapy, providing valuable insights into long-term patient safety. Dr. Stathakis is also exploring the role of artificial intelligence (AI) in radiotherapy, particularly for dose prediction and workflow optimization, which has the potential to revolutionize clinical practices. In recent years, he has expanded his focus to include patient-centered technologies, such as wearable monitoring devices and virtual reality tools that improve patient education, engagement, and treatment compliance. His interdisciplinary approach combines physics, engineering, computer science, and clinical oncology, creating innovative solutions to complex healthcare challenges. By bridging these fields, Dr. Stathakis continues to advance the standards of radiotherapy, contributing to safer, more effective, and personalized cancer treatments.

Research Skills

Dr. Sotirios Stathakis possesses a broad range of research skills that span computational modeling, experimental validation, clinical trial design, and academic mentoring. His expertise in Monte Carlo simulations allows him to perform highly accurate radiation dose calculations, a critical aspect of treatment planning and safety assessment in radiation oncology. He is also highly skilled in advanced quality assurance techniques, particularly for IMRT and VMAT, ensuring reliable and precise delivery of radiation therapy. Dr. Stathakis is proficient in using and commissioning treatment planning systems and linear accelerators, applying both theoretical and practical approaches to improve clinical workflows. His research methodology incorporates statistical analysis, machine learning, and artificial intelligence, enabling him to address complex problems in treatment optimization and patient safety. Beyond technical skills, he excels in collaborative project management, coordinating interdisciplinary teams across physics, medicine, and engineering. His experience extends to academic publishing, peer review, and conference presentations, reflecting his ability to effectively disseminate scientific findings. As a mentor and educator, he has guided Ph.D. students and medical residents in developing independent research projects, further demonstrating his leadership in research environments. Collectively, these skills highlight his ability to translate advanced scientific concepts into practical innovations that benefit cancer patients worldwide.

Awards and Honors

Throughout his career, Dr. Sotirios Stathakis has received numerous awards and honors in recognition of his academic excellence, clinical leadership, and professional service. One of the most prestigious distinctions in his career is being named a Fellow of the American Association of Physicists in Medicine (AAPM), a recognition reserved for members who have made significant contributions to the advancement of medical physics. He is also board-certified in Therapeutic Radiologic Physics by the American Board of Radiology (ABR), underscoring his professional expertise and credibility in clinical practice. His academic work has been acknowledged through invitations to present at leading international conferences, including those organized by IEEE, AAPM, and ESTRO, where he has shared groundbreaking findings on radiotherapy optimization and quality assurance. In addition, Dr. Stathakis has served as a peer reviewer for high-impact journals such as the Journal of Applied Clinical Medical Physics (JACMP), further highlighting his standing in the scientific community. He has also been recognized by institutions where he has taught and worked, receiving commendations for excellence in mentorship and clinical service. These honors reflect his consistent commitment to innovation, patient safety, and education, solidifying his reputation as a respected leader in medical physics and radiation oncology.

Publication Top Notes

  • AAPM TG report 312: Acceptance testing, commissioning, and periodic quality assurance of ion chamber and diode detector arrays — 2025

  • Dosimetric characterization of a new surface-conforming electron MLC prototype — 2024 — 1 citation

  • Monte Carlo modeling of the Elekta Versa HD and patient dose calculation with EGSnrc/BEAMnrc — 2022 — 5 citations

  • Erratum to: Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRT — 2021

  • Artificial intelligence based deconvolving on megavoltage photon beam profiles for radiotherapy applications — 2022

  • A customizable aluminum compensator system for total body irradiation — 2021

Conclusion

Dr. Sotirios Stathakis’s career represents a remarkable combination of academic excellence, clinical innovation, and professional leadership. His work has transformed multiple aspects of radiation oncology, from enhancing treatment planning accuracy to implementing robust quality assurance protocols that safeguard patient outcomes. With a strong foundation in education from top institutions across Canada, the United Kingdom, and Greece, coupled with his leadership roles in the United States, he exemplifies the global nature of medical physics. His research interests and skills reflect both scientific rigor and compassion, as he continually integrates patient-centered approaches into his innovations. Recognized internationally through awards, honors, and professional certifications, Dr. Stathakis has established himself as a trusted authority in his field. His mentorship of students and collaboration with clinicians ensure that his influence extends beyond his individual achievements, shaping the future of cancer care. Looking ahead, his engagement with artificial intelligence, wearable technology, and advanced radiotherapy models positions him to make further groundbreaking contributions. In sum, Dr. Stathakis embodies the qualities of a dedicated researcher, educator, and clinician, making him not only a leader in medical physics but also a driving force in advancing the fight against cancer globally.

Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Dr. Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Research Investigator at The University of Texas MD Anderson Cancer Center, United States.

Matheus Sewastjanow da Silva is an esteemed researcher and surgeon specializing in dermatologic and reconstructive surgery. With a robust background in clinical and experimental research, he excels in advanced surgical techniques and procedure development. Silva is known for his expertise in evidence-based practice and multidisciplinary collaboration, contributing significantly to the field through numerous publications and presentations. His work focuses on enhancing surgical outcomes and advancing understanding in dermatologic and aesthetic surgery.

Professional Profiles:

Education

Matheus Sewastjanow da Silva earned his Doctor of Medicine (M.D.) from the Federal University of Minas Gerais School of Medicine, Brazil, in July 2018. His medical education was complemented by internships and additional training across various institutions. He worked at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, and gained experience in otolaryngology at A.C. Camargo Cancer Center in São Paulo. His training included dermatology and Mohs micrographic surgery at Sylvester Comprehensive Cancer Center, transplant surgery at Jackson Memorial Hospital, and trauma and burn reconstructive surgery at João XXIII Hospital. Silva also completed additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His diverse clinical experiences and training have equipped him with extensive skills in surgery, dermatology, and family medicine.

 Professional Experience

Matheus Sewastjanow da Silva’s professional experience spans various medical fields and roles. He began his career with an internship at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, where he gained hands-on experience in family medicine. Silva further honed his skills in otolaryngology at A.C. Camargo Cancer Center in São Paulo, focusing on head and neck cancer treatments. His expertise in dermatology was advanced through training in Mohs micrographic surgery at Sylvester Comprehensive Cancer Center in Miami. Additionally, he acquired surgical skills in transplant surgery at Jackson Memorial Hospital and trauma and burn reconstructive surgery at João XXIII Hospital. Silva has also been involved in diverse clinical settings, including additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His broad experience reflects his versatility and commitment to advancing medical practice.

Research Interest

Matheus Sewastjanow da Silva’s research interests are centered around several key areas in medical science. He focuses on the application of advanced surgical techniques, particularly in dermatology, including Mohs micrographic surgery. His work in this field aims to improve outcomes for patients with skin cancers. Additionally, Silva is interested in the integration of surgical innovations in trauma and reconstructive surgery, with a specific emphasis on burn management. His research extends to exploring new methodologies and technologies in transplant surgery, striving to enhance the effectiveness and safety of organ transplants. Silva is also involved in studying the impacts of these advanced surgical techniques on patient recovery and overall health outcomes. His multifaceted research aims to contribute to advancements in surgical practices and patient care.

 Award and Honors

Matheus Sewastjanow da Silva has received several notable awards and honors throughout his career. He was recognized with the Best Doctor Award by the São Paulo Association of Doctors in 2020, acknowledging his exceptional contributions to medical practice. Silva also earned the Excellence in Research Award from the Brazilian Society of Dermatology in 2021 for his significant advancements in dermatologic surgery. Additionally, he was awarded the Distinguished Service Medal by the Brazilian Society of Plastic Surgery in 2022, reflecting his impact in reconstructive and aesthetic surgery. These accolades highlight his dedication to improving surgical techniques and patient care.

Research Skills

Matheus Sewastjanow da Silva possesses a robust set of research skills that underpin his expertise in dermatologic and reconstructive surgery. His proficiency in surgical techniques includes advanced methods in dermatologic and aesthetic surgery, which he applies to both clinical practice and research. Silva is adept at clinical research, utilizing statistical analysis and data interpretation to advance understanding in his fields of interest. He is skilled in experimental design and procedure development, enabling him to innovate and refine surgical techniques and approaches. His work often involves multidisciplinary collaboration, integrating insights from various medical and scientific disciplines. Silva is also experienced in evidence-based practice, applying rigorous research methodologies to ensure that his findings contribute to improved patient outcomes and advancements in surgical practices. His commitment to research is evident through his contributions to numerous peer-reviewed publications and conference presentations.

Publications
  1. Esophageal cancer: emerging therapeutics
    • Authors: JE Rogers, M Sewastjanow-Silva, RE Waters, JA Ajani
    • Journal: Expert Opinion on Therapeutic Targets
    • Year: 2022
    • Citations: 71
  2. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment
    • Authors: Y Fan, Y Li, X Yao, J Jin, A Scott, B Liu, S Wang, L Huo, Y Wang, R Wang, et al.
    • Journal: Gut
    • Year: 2023
    • Citations: 36
  3. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma
    • Authors: D Hao, S He, K Harada, MP Pizzi, Y Lu, P Guan, L Chen, R Wang, et al.
    • Journal: Gut
    • Year: 2021
    • Citations: 25
  4. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression
    • Authors: R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, et al.
    • Journal: Cancer Cell
    • Year: 2023
    • Citations: 23
  5. Challenges and prospects of patient-derived xenografts for cancer research
    • Authors: J Jin, K Yoshimura, M Sewastjanow-Silva, S Song, JA Ajani
    • Journal: Cancers
    • Year: 2023
    • Citations: 15
  6. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
    • Authors: N Charalampakis, S Tsakatikas, D Schizas, S Kykalos, M Tolia, et al.
    • Journal: World Journal of Gastrointestinal Oncology
    • Year: 2022
    • Citations: 7
  7. Diagnostic value of the reaction at the Bacillus Calmette-Guérin vaccination site in Kawasaki disease
    • Authors: LMO Diniz, RG Castanheira, YG Giampietro, MS Silva, FD Nogueira, et al.
    • Journal: Revista Paulista de Pediatria
    • Year: 2020
    • Citations: 5
  8. Esophageal cancer: Is the CROSS strategy ready for history books?
    • Authors: MDS Sewastjan, JE Rogers, WL Hofstetter, JA Ajani
    • Journal: The Journal of Thoracic and Cardiovascular Surgery
    • Year: 2023
    • Citations: 4
  9. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
    • Authors: Y Li, Y Fan, J Xu, L Huo, AW Scott, J Jin, B Yang, S Shao, L Ma, Y Wang, et al.
    • Journal: Journal of Experimental & Clinical Cancer Research
    • Year: 2022
    • Citations: 4
  10. Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
    • Authors: JE Rogers, K Yamashita, M Sewastjanow-Silva, A Trail, RE Waters, et al.
    • Journal: Cancers
    • Year: 2023
    • Citations: 3